Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This artificial peptide resembles the actions of naturally produced GLP-1, a hormone that plays a crucial role in controlling blood insulin response. By enhancing GLP-1 receptors in the pancreas, Retasturtide f